Debt-to-equity of Kura Oncology, Inc. from 31 Mar 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Kura Oncology, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2014 to 31 Dec 2025.
  • Kura Oncology, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 159%, a 476% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Kura Oncology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 159% +131% +476% 31 Dec 2025
Q3 2025 114% +102% +897% 30 Sep 2025
Q2 2025 77% +66% +614% 30 Jun 2025
Q1 2025 50% +40% +397% 31 Mar 2025
Q4 2024 28% +18% +188% 31 Dec 2024
Q3 2024 11% +2.9% +34% 30 Sep 2024
Q2 2024 11% +3.1% +40% 30 Jun 2024
Q1 2024 10% +3.1% +44% 31 Mar 2024
Q4 2023 9.6% +3.4% +56% 31 Dec 2023
Q3 2023 8.6% +3.1% +58% 30 Sep 2023
Q2 2023 7.7% +2.6% +52% 30 Jun 2023
Q1 2023 7% +2% +39% 31 Mar 2023
Q4 2022 6.2% +0.87% +16% 31 Dec 2022
Q3 2022 5.4% -0.03% -0.48% 30 Sep 2022
Q2 2022 5% -1.3% -20% 30 Jun 2022
Q1 2022 5% -2.4% -32% 31 Mar 2022
Q4 2021 5.3% -3.3% -38% 31 Dec 2021
Q3 2021 5.4% -5% -48% 30 Sep 2021
Q2 2021 6.3% -3.7% -37% 30 Jun 2021
Q1 2021 7.4% -2.2% -23% 31 Mar 2021
Q4 2020 8.5% -1.3% -13% 31 Dec 2020
Q3 2020 10% +0.17% +1.6% 30 Sep 2020
Q2 2020 10% -0.55% -5.2% 30 Jun 2020
Q1 2020 9.6% -3% -24% 31 Mar 2020
Q4 2019 9.8% -2.8% -22% 31 Dec 2019
Q3 2019 10% -3.3% -24% 30 Sep 2019
Q2 2019 11% -5.1% -33% 30 Jun 2019
Q1 2019 13% -4.8% -27% 31 Mar 2019
Q4 2018 13% -7.9% -38% 31 Dec 2018
Q3 2018 14% -7.6% -36% 30 Sep 2018
Q2 2018 16% -7.4% -32% 30 Jun 2018
Q1 2018 17% -2.9% -14% 31 Mar 2018
Q4 2017 20% +4.9% +31% 31 Dec 2017
Q3 2017 21% +9.6% +83% 30 Sep 2017
Q2 2017 23% +13% +134% 30 Jun 2017
Q1 2017 20% +13% +160% 31 Mar 2017
Q4 2016 16% +6% +63% 31 Dec 2016
Q3 2016 12% -4.2% -27% 30 Sep 2016
Q2 2016 9.9% -7.2% -42% 30 Jun 2016
Q1 2016 7.8% -17% -68% 31 Mar 2016
Q4 2015 9.6% +146% 31 Dec 2015
Q3 2015 16% +123% 30 Sep 2015
Q2 2015 17% +124% 30 Jun 2015
Q1 2015 24% +135% 31 Mar 2015
Q4 2014 -137% 31 Dec 2014
Q3 2014 -107% 30 Sep 2014
Q2 2014 -107% 30 Jun 2014
Q1 2014 -110% 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.